Introduction
Compliance is the extent to which a person's behavior coincides with medical or health advices. Compliance behavior depends on the specific clinical situation, the nature of the illness, and the treatment program. 1 The reasons for noncompliance may include discomfort resulting from treatment, expense of treatment, decisions based on personal judgments about the effectiveness of the proposed treatment, maladaptive coping styles (e.g., denial of illness), or mental disorders. 
Summary
Background: Compliance behavior depends on the specific clinical situation, the nature of the illness, and the treatment program. The aim of this study was to determine the rate of drug compliance in families caring for a child or adolescent with epilepsy and to describe some associated factors. Methods: All the patients with epilepsy under 18 years of age who were attending the Motahary Clinic of Shiraz for a six-month period and their families were interviewed. Results: The total number of participants was 181 patients. Drug compliance was satisfactory in 72.4% of the patients. Etiology of epilepsy, mono-therapy versus polytherapy, duration of the disease, age of the patient, accompanying disease, parental smoking, parental education and living in urban versus rural areas did not significantly influence the drug compliance but maternal age was significantly higher in patients with poor compliance. Also, patients with positive family history of epilepsy had more noncompliance. Moreover, family size had a significant effect on drug compliance. Finally, patients using phenobarbital were more complaint than other patients. Conclusions: In this study, drug compliance was satisfactory in almost three-fourths of the patients with epilepsy. There was no significant association between noncompliance and the cause of epilepsy, duration of the disease, socio-economic status (parental smoking, living place, education) and number of drugs used to treat the illness. But paying attention to medication education for patients and parents, decreasing the complexity of the treatment regimen and younger possibly more motivated mothers in a small family, increased the drug compliance. It is a common belief that adolescents with epilepsy show good compliance with their medication because a neglect of medical treatment may cause epileptic seizures. However, Chander et al. found that adolescents with epilepsy showed poor compliance, 2 and in two other studies one-third of the adolescents with epilepsy showed poor compliance. 3, 4 The aim of this study was to determine the rate of drug compliance in families caring for a child or adolescent with epilepsy according to their selfreport of medication usage and to describe some factors that affect drug compliance.
Methods
All the patients with epilepsy under 18 years of age who were attending the Motahary Clinic of Shiraz University of Medical Sciences from January 2004 to June 2004 and their families were interviewed after signing an informed consent in this cross-sectional study. The data were collected by means of interview with the parents and/or patients. The collected data consisted of items on the following topics: compliance for medication taking according to their self or parental report, the subjective reason for noncompliance (including irregular taking, errors of dosage and partial or total omission), sex, age, duration of disease, treatment regimen, associated illness (cerebral palsy and/or mental retardation), family history of epilepsy, sib ship size, age and educational level of parents, history of parental smoking and living place. Drug compliance was considered as satisfactory if the patient took the medication in correct dosage, regularly and as planned for him/her either by his/her own or given by the parents based on their yes/no response to the questions about the above-mentioned items.
Frequencies and description statistics were computed. The connections between the above-mentioned factors to drug compliance were analyzed by Pearson chi-square, logistic regression and T-test.
Results
The total number of participants was 181 patients. Their mean age was 7 AE 4.6 years. The mean age of the onset of their disease was 4.9 AE 4.2 years. The sex ratio (male to female) of these patients was 1.29. The etiology of epilepsy was specified in 21.5% of the patients, but epilepsy was idiopathic in 78.5% of them. Epilepsy in 87.3% of the patients was generalized, in 8.3% partial and in 4.4% unclassified. The most common types of epilepsy were generalized tonic-clonic seizures (36.5%), myoclonic seizures (19.9%), and tonic seizures (17%).
The most common drugs prescribed were phenobarbital (33.7%), which was prescribed once at night (q.h.s.) and carbamazepine (27.6%) and valproic acid (18.8), which were prescribed twice or thrice a day (b.i.d./t.i.d.). In 10.5% of the patients, two drugs were used to control the disease, and in 6.1% of them more than two drugs were used.
Drug compliance was satisfactory in 72.3% and was poor in 27.7% of the patients according to their self or parental report. Five percent of the patients refused to participate, who were omitted from the study. The reason for noncompliance was minor drug side effects (drowsiness, gastro-intestinal upset) in 7.5% of them but 92.5% of noncompliant patients did not adhere to the treatment due to personal judgment about the advantages and disadvantages of the proposed treatment, or denial of illness as their coping style.
Drug compliance in patients with idiopathic epilepsy did not differ significantly from the patients with symptomatic epilepsy (P = 0.428). Compliance in patients on mono-therapy did not differ significantly from other patients (P = 0.631). Duration of the disease did not have a significant effect on compliance (2.4 AE 1.9 years in the patients with poor compliance in comparison to 2.2 AE 2.4 years in the patients with good compliance, P = 0.576). Compliance was not significantly different in children (less than 12 years old) and adolescents (P = 0.07). Accompanying disease (cerebral palsy or mental retardation) (P = 0.937), parental smoking (P = 0.115), parental education (P > 0.05), living in urban versus rural areas (P = 0.394) did not significantly influence the compliance but maternal age was significantly higher in patients with poor compliance (P = 0.043 with logistic regression and P = 0.04 with T-test). It was 26.2 AE 6.5 years in patients with poor compliance and 24 AE 5.6 years in others.
Also, patients with positive family history of epilepsy had more noncompliance than patients with negative family history (32.8% versus 18.3%, P = 0.029). Family size also had a significant effect on compliance (with logistic regression: P = 0.0001, B = À0.391). In patients with poor compliance, family size was 6 AE 2 persons and in others it was 4.6 AE 1.6. Finally, patients using phenobarbital which was prescribed q.h.s. were more complaint than those using carbamazepine or valproic acid which were prescribed twice or thrice daily (88% versus 67.1%, P = 0.004).
Discussion
Compliance, also known as adherence, is the degree to which a patient carries out the clinical recommendations of the treating physician. Compliance behavior depends on the specific clinical situation, the nature of the illness, and the treatment program. An increased complexity of treatment regimen, as well as an increased number of required behavioral changes, appears to be associated with noncompliance. 1 In this study, drug compliance was satisfactory in almost three-fourths of the patients with epilepsy. This rate is higher than what was seen in the adolescents previously. 3, 4 At the first look, it may seem that because all the children and adolescents were included in this study, and parents play a more active role in the treatment program in children, compliance was higher in this study, but there was no significant difference between compliance of children (less than 12 years old) and adolescents in this study.
In this study, there was not significant association between noncompliance and the cause of epilepsy (idiopathic versus symptomatic), duration of disease, and socio-economic status (parental smoking, living place, education). However, higher maternal age, larger family size and positive family history of epilepsy were significantly associated with noncompliance. These findings signify the role of parents, especially mothers in caring for children with epilepsy. Besides, appropriate family planning, especially in families having a previous diseased child, helps improving the compliance with treatment in families caring for a child with a chronic disease like epilepsy.
Also, an increased complexity of the drug regimen was associated with noncompliance, as the patients with once daily regimen had more compliance than others. In a previous study, it was observed that compliance is enhanced with twice daily dosage as compared to three or more times daily dosages. 5 It seems that formulating the anticonvulsant drugs in a way that they could be prescribed once daily may increase the drug compliance in the patients with epilepsy.
Interestingly, the number of the drugs used to treat the illness, was not significantly associated with noncompliance. In contrast, being on mono-therapy was described as a strong predictor of noncompliance in the research done by Buck et al. 6 However, it is important to clearly and precisely determine the role of various aspects of complexity of the drug regimen in regard to treatment compliance in the patients with epilepsy in future studies.
To improve and ensure compliance of epileptic children and adolescents and their families, paying attention to psychological health of the child, 7 group education, 8 medication education for patients and parents, especially through written information, 9 and support from parents and physicians 4, 10, 11 are important and useful. Also, decreasing the complexity of the treatment regimen and younger and possibly more motivated mothers in a small family with appropriate family planning are the factors that increase the drug compliance of these patients and their families.
